Overview Of Kidney cancer
Kidney cancer, also known as renal cancer, is a type of cancer that originates in the kidneys, the two bean-shaped organs responsible for filtering waste from the blood and producing urine. The most common type of kidney cancer in adults is renal cell carcinoma (RCC), which accounts for about 90% of cases. Other less common types include transitional cell carcinoma and Wilms tumor, which primarily affects children. Kidney cancer often develops as a single tumor in one kidney, but it can also occur in both kidneys simultaneously. Early-stage kidney cancer may not cause noticeable symptoms, making it challenging to detect without screening. However, as the disease progresses, symptoms such as blood in the urine, persistent pain in the side or lower back, and unexplained weight loss may appear. Treatment options vary depending on the stage and type of cancer, ranging from surgery to targeted therapies and immunotherapy.
Symptoms of Kidney cancer
- Kidney cancer symptoms often do not appear in the early stages, but as the tumor grows, several signs may emerge. The most common symptom is hematuria, or blood in the urine, which may appear pink, red, or cola-colored. Persistent pain in the side or lower back that does not go away is another frequent symptom. Unexplained weight loss, fatigue, and a general feeling of being unwell are also associated with kidney cancer. Some patients may experience a palpable lump or mass in the abdomen. Fever, night sweats, and swelling in the legs or ankles can occur in more advanced cases. It is important to note that these symptoms can also be caused by other conditions, so a thorough medical evaluation is necessary to confirm a diagnosis of kidney cancer.
Causes of Kidney cancer
- The exact cause of kidney cancer is not fully understood, but several factors are known to increase the risk of developing the disease. Genetic mutations play a significant role, with certain inherited conditions such as von Hippel-Lindau disease, hereditary papillary renal cell carcinoma, and Birt-Hogg-Dubé syndrome being linked to a higher risk of kidney cancer. Environmental and lifestyle factors also contribute, including smoking, obesity, and prolonged exposure to harmful chemicals such as asbestos, cadmium, and certain herbicides. Chronic kidney disease and long-term dialysis treatment are additional risk factors. High blood pressure has also been associated with an increased likelihood of developing kidney cancer. While these factors do not guarantee the development of the disease, they significantly elevate the risk and highlight the importance of preventive measures.
Risk Factors of Kidney cancer
- Several risk factors increase the likelihood of developing kidney cancer:
- Smoking: Smokers are at a higher risk compared to non-smokers, and the risk decreases after quitting.
- Obesity: Excess body weight is linked to hormonal changes that may contribute to kidney cancer.
- High Blood Pressure: Hypertension is a significant risk factor, though the exact mechanism is not fully understood.
- Family History: A family history of kidney cancer or inherited genetic syndromes increases susceptibility.
- Occupational Exposure: Prolonged exposure to chemicals like asbestos, cadmium, and certain herbicides elevates risk.
- Chronic Kidney Disease: Patients with long-term kidney disease or those on dialysis are more prone to kidney cancer.
- Age and Gender: Kidney cancer is more common in individuals over 60 and is more prevalent in men than women. Understanding these risk factors can help in early detection and preventive strategies.
Prevention of Kidney cancer
- While there is no guaranteed way to prevent kidney cancer, certain lifestyle changes can reduce the risk. Quitting smoking is one of the most effective measures, as it significantly lowers the likelihood of developing kidney cancer. Maintaining a healthy weight through a balanced diet and regular exercise can also reduce risk, as obesity is a known risk factor. Managing high blood pressure and avoiding prolonged exposure to harmful chemicals, such as those found in certain workplaces, are additional preventive strategies. Regular medical check-ups and screenings are important, especially for individuals with a family history of kidney cancer or other risk factors. Early detection through routine health exams can improve outcomes and provide more treatment options.
Prognosis of Kidney cancer
- The prognosis for kidney cancer varies depending on the stage at diagnosis, the type of cancer, and the patient’s overall health. Early-stage kidney cancer that is localized to the kidney has a higher survival rate, with many patients achieving long-term remission after surgery. The five-year survival rate for localized kidney cancer is approximately 93%. However, if the cancer has spread to nearby lymph nodes or distant organs, the prognosis is less favorable, with a five-year survival rate dropping to around 12% for metastatic cases. Advances in targeted therapies and immunotherapy have improved outcomes for some patients with advanced kidney cancer. Regular follow-up care is essential to monitor for recurrence and manage any side effects of treatment.
Complications of Kidney cancer
- Kidney cancer and its treatment can lead to several complications. Surgical removal of a kidney may result in reduced kidney function, especially if the remaining kidney is not fully healthy. This can lead to chronic kidney disease or even kidney failure in severe cases. Metastasis, or the spread of cancer to other organs such as the lungs, bones, or liver, is a significant complication that can worsen prognosis. Treatment side effects, such as fatigue, nausea, and immune-related adverse events from immunotherapy, can impact quality of life. Blood clots, high blood pressure, and anemia are other potential complications. Psychological effects, including anxiety and depression, are also common among cancer patients and should be addressed as part of comprehensive care.
Related Diseases of Kidney cancer
- Kidney cancer is associated with several related diseases and conditions. Chronic kidney disease (CKD) is a significant risk factor and can also be a complication of kidney cancer treatment. Polycystic kidney disease, a genetic disorder characterized by the growth of numerous cysts in the kidneys, may increase the risk of kidney cancer. Inherited syndromes such as von Hippel-Lindau disease, hereditary leiomyomatosis, and Birt-Hogg-Dubé syndrome are strongly linked to kidney cancer. Additionally, kidney cancer can metastasize to other organs, leading to secondary cancers in the lungs, bones, or liver. Other related conditions include hypertension, which is both a risk factor and a potential complication, and anemia, which can result from chronic kidney disease or cancer treatment. Understanding these related diseases is crucial for comprehensive care and management.
Treatment of Kidney cancer
Treatment for kidney cancer depends on the stage and type of cancer, as well as the patient’s overall health. Surgery is the most common treatment and may involve removing part of the kidney (partial nephrectomy) or the entire kidney (radical nephrectomy). For advanced cases, targeted therapy drugs that specifically attack cancer cells may be used. Immunotherapy, which boosts the body’s immune system to fight cancer, is another option. Radiation therapy and chemotherapy are less commonly used for kidney cancer but may be considered in certain situations. In cases where surgery is not possible, ablation techniques such as cryoablation or radiofrequency ablation may be used to destroy cancer cells. Treatment plans are often tailored to the individual, and a multidisciplinary approach involving oncologists, urologists, and other specialists is typically employed.
Generics For Kidney cancer
Our administration and support staff all have exceptional people skills and trained to assist you with all medical enquiries.

Everolimus
Everolimus

Sorafenib
Sorafenib

Sunitinib
Sunitinib

Bevacizumab
Bevacizumab

Pazopanib Hydrochloride
Pazopanib Hydrochloride

Everolimus
Everolimus

Sorafenib
Sorafenib

Sunitinib
Sunitinib

Bevacizumab
Bevacizumab

Pazopanib Hydrochloride
Pazopanib Hydrochloride